Income statement
USD
Annual
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 0 | 1M | 0 | 0 |
| Gross Profit | 0 | 745K | 0 | 0 |
| Operating Income | -945K | -196K | -486K | -71K |
| EBITDA | -945K | -71K | -486K | 0 |
| Net Income | 6M | -71K | -486K | -71K |
| EPS (Diluted) | — | — | — | — |
Financial Services
Live Price
Offline$0.185
+0.00% today
1Y Change
+288.06%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 139 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Translational Development Acquisition Corp. (TDACW) is a Financial Services stock with a market cap of $230.00M and listed on NASDAQ. The stock last traded around $0.18 and up 288.1% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +2384.0%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +2384.0%, free cash flow +28.5% with operating margin 0.0% and ROIC -0.5%. Valuation sits in the middle of the pack at P/E 28.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TDACW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TDACW
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TDACW Max Drawdown
-58.60%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TDACW and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$70.7K
+85.4% YoY
Free Cash Flow
-$145.0
+28.9% YoY
Revenue Growth
-100.0%
EPS Growth
+2384.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 0 | 1M | 0 | 0 |
| Gross Profit | 0 | 745K | 0 | 0 |
| Operating Income | -945K | -196K | -486K | -71K |
| EBITDA | -945K | -71K | -486K | 0 |
| Net Income | 6M | -71K | -486K | -71K |
| EPS (Diluted) | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & Equivalents | 30K | 438K | 2K | 2K |
| Total Assets | 182M | 175M | 2K | 437K |
| Total Liabilities | 7M | 6M | 510K | 459K |
| Shareholder Equity | -7M | 169M | -508K | -22K |
| Total Debt | 0 | 6110.8B | 348K | 259K |
| Net Debt | -30K | -438K | 345K | 257K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
145
+28.9% YoY
Capital Expenditures
4
Free Cash Flow
145
+28.9% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
3.7%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.